{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T13:44:49Z","timestamp":1763300689381,"version":"3.45.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>X-linked hypophosphatemia (XLH) is caused by mutations in the PHEX gene, which leads to increased levels of fibroblast growth factor 23 and hypophosphatemia, contributing to rickets, osteomalacia, and dentoalveolar defects, including severe dentin hypomineralization, thin cementum, and alveolar bone osteomalacia. Current XLH treatment options appear to have limited efficacy on dentoalveolar tissues, suggesting underlying disease mechanisms that remain unchecked. Increased production of inorganic pyrophosphate (PPi) and osteopontin (OPN), both mineralization inhibitors, has been posited to contribute to mineralization defects in XLH. The enzyme, tissue-nonspecific alkaline phosphatase (TNAP) reduces PPi levels via hydrolysis and inactivates OPN by dephosphorylation. Our previous study showed improved alveolar bone socket healing in Hyp mice administered mineralized tissue-targeted TNAP (TNAP-Fc-D10). We hypothesized that increased TNAP would partially ameliorate developmental mineralization defects in XLH by dually reducing PPi levels and dephosphorylating and inactivating OPN. In a proof-of-principle study to investigate pathological mechanisms, we delivered systemic (subcutaneous injection) and local (submucosal injection to mandibles) TNAP-Fc-D10 injections to the Hyp mutant mouse model of XLH from 7 to 60\u00a0d postnatal (dpn). While systemic delivery was ineffective at improving dentin or bone properties, micro-CT and histology analyses demonstrated that local delivery of TNAP-Fc-D10 increased dentin thickness, root length, alveolar bone volume, alveolar bone proper (ABP) volume and density, PDL attachment, and acellular cementum thickness, compared to control Hyp mice receiving a sham injection. Dynamic mechanical testing confirmed partially improved mechanical properties in locally treated vs untreated Hyp mice, suggesting incompletely improved periodontal function. Quantitative PCR revealed increased Dspp expression in molars of treated Hyp mice. In conclusion, we found TNAP administration reduced dentoalveolar defects in Hyp mice when delivered locally into dentoalveolar structures, proof-of-principle pointing to a pathological contribution by PPi and\/or OPN and highlighting a promising adjunctive approach considering limitations of current treatment modalities.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziaf166","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:26:06Z","timestamp":1760617566000},"source":"Crossref","is-referenced-by-count":0,"title":["Proof-of-principle for enhanced dentoalveolar mineralization using exogenous tissue-nonspecific alkaline phosphatase in the\n                    <i>Hyp<\/i>\n                    mouse model of X-linked hypophosphatemia"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1848-0335","authenticated-orcid":false,"given":"Aonjittra","family":"Phanrungsuwan","sequence":"first","affiliation":[{"name":"Division of Biosciences, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bella","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Division of Biosciences, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-6541","authenticated-orcid":false,"given":"Fatma F","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Division of Biosciences, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7683-0707","authenticated-orcid":false,"given":"Kedith","family":"Sawangsri","sequence":"additional","affiliation":[{"name":"Division of Restorative and Prosthetic Dentistry, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karli","family":"Belgya","sequence":"additional","affiliation":[{"name":"Division of Biosciences, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara N","family":"Kolli","sequence":"additional","affiliation":[{"name":"Division of Biosciences, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinju","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Orthodontics, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-1254","authenticated-orcid":false,"given":"Do-Gyoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Orthodontics, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-6694","authenticated-orcid":false,"given":"Flavia Amadeu","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Sanford Children's Health Research Center, Sanford Burnham Prebys Medical Discovery Institute , La Jolla, CA 92037,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-6916","authenticated-orcid":false,"given":"Eva S","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1547-2671","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Mill\u00e1n","sequence":"additional","affiliation":[{"name":"Sanford Children's Health Research Center, Sanford Burnham Prebys Medical Discovery Institute , La Jolla, CA 92037,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3444-0576","authenticated-orcid":false,"given":"Brian L","family":"Foster","sequence":"additional","affiliation":[{"name":"Division of Biosciences, College of Dentistry, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"5","key":"2025111608424866600_ref1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41581-025-00939-0","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"21","author":"Haffner","year":"2025","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2025111608424866600_ref2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13023-023-02882-4","article-title":"The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data","volume":"18","author":"Ariceta","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2025111608424866600_ref3","doi-asserted-by":"publisher","first-page":"e10463","DOI":"10.1002\/jbm4.10463","article-title":"Mineralization defects in the primary dentition associated with X-linked hypophosphatemic rickets","volume":"5","author":"Clayton","year":"2021","journal-title":"JBMR Plus"},{"issue":"11","key":"2025111608424866600_ref4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.adaj.2024.05.016","article-title":"Inherited phosphate and pyrophosphate disorders: new insights and novel therapies changing the oral health landscape","volume":"155","author":"Foster","year":"2024","journal-title":"J Am Dent Assoc"},{"issue":"7","key":"2025111608424866600_ref5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc"},{"issue":"1","key":"2025111608424866600_ref6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00198-020-05548-0","article-title":"Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review","volume":"32","author":"Seefried","year":"2021","journal-title":"Osteoporos Int"},{"issue":"11","key":"2025111608424866600_ref7","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025111608424866600_ref8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf356","article-title":"Systematic review: efficacy of medical therapy on outcomes important to pediatric patients with X-linked hypophosphatemia","volume":"110","author":"Ali","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025111608424866600_ref9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad704","article-title":"Systematic review: efficacy of medical therapy on outcomes important to adult patients with X-linked hypophosphatemia","volume":"110","author":"Ali","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025111608424866600_ref10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41368-023-00259-8","article-title":"Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia","volume":"15","author":"Lira","year":"2023","journal-title":"Int J Oral Sci"},{"issue":"13","key":"2025111608424866600_ref11","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1177\/00220345211011041","article-title":"Effects of active vitamin D or FGF23 antibody on Hyp mice dentoalveolar tissues","volume":"100","author":"Lira Dos Santos","year":"2021","journal-title":"J Dent Res"},{"issue":"10189","key":"2025111608424866600_ref12","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"2025111608424866600_ref13","doi-asserted-by":"publisher","first-page":"e10672","DOI":"10.1002\/jbm4.10672","article-title":"Burosumab and dental abscesses in children with X-linked hypophosphatemia","volume":"6","author":"Gadion","year":"2022","journal-title":"JBMR Plus"},{"key":"2025111608424866600_ref14","doi-asserted-by":"publisher","first-page":"947814","DOI":"10.3389\/fendo.2022.947814","article-title":"Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy","volume":"13","author":"Brener","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2025111608424866600_ref15","doi-asserted-by":"publisher","first-page":"e3241","DOI":"10.1038\/s41416-025-03227-7","article-title":"Effect of burosumab compared with conventional therapy on younger vs older children with X-linked hypophosphatemia","volume":"107","author":"Ward","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025111608424866600_ref16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11914-021-00669-9","article-title":"Burosumab for pediatric X-linked hypophosphatemia","volume":"19","author":"Imel","year":"2021","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"2025111608424866600_ref17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00223-001-1121-z","article-title":"Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone","volume":"71","author":"Boskey","year":"2002","journal-title":"Calcif Tissue Int"},{"issue":"Pt 3","key":"2025111608424866600_ref18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1042\/BJ20031150","article-title":"Inhibition of hydroxyapatite formation by osteopontin phosphopeptides","volume":"378","author":"Pampena","year":"2004","journal-title":"Biochem J"},{"issue":"21","key":"2025111608424866600_ref19","doi-asserted-by":"publisher","first-page":"15872","DOI":"10.1074\/jbc.M701116200","article-title":"Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity","volume":"282","author":"Addison","year":"2007","journal-title":"J Biol Chem"},{"issue":"3","key":"2025111608424866600_ref20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/jbmr.1766","article-title":"Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia","volume":"28","author":"Barros","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025111608424866600_ref21","doi-asserted-by":"publisher","first-page":"e1002427","DOI":"10.1371\/journal.pbio.1002427","article-title":"Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice","volume":"14","author":"Murali","year":"2016","journal-title":"PLoS Biol"},{"key":"2025111608424866600_ref22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bone.2016.11.019","article-title":"Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia","volume":"95","author":"Boukpessi","year":"2017","journal-title":"Bone"},{"issue":"10","key":"2025111608424866600_ref23","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/jbmr.4101","article-title":"Genetic ablation of osteopontin in osteomalacic Hyp mice partially rescues the deficient mineralization without correcting hypophosphatemia","volume":"35","author":"Hoac","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2025111608424866600_ref24","doi-asserted-by":"publisher","first-page":"116886","DOI":"10.1016\/j.bone.2023.116886","article-title":"Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice","volume":"176","author":"Mohamed","year":"2023","journal-title":"Bone"},{"issue":"4","key":"2025111608424866600_ref25","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0002-9440(10)63208-7","article-title":"Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders","volume":"164","author":"Harmey","year":"2004","journal-title":"Am J Pathol"},{"issue":"4","key":"2025111608424866600_ref26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2025111608424866600_ref27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2025111608424866600_ref28","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/jbmr.1901","article-title":"In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin","volume":"28","author":"Narisawa","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2025111608424866600_ref29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-981-13-7709-9_13","article-title":"Alkaline phosphatase replacement therapy for hypophosphatasia in development and practice","volume":"1148","author":"Bowden","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"2025111608424866600_ref30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1359\/jbmr.071213","article-title":"Enzyme replacement therapy for murine hypophosphatasia","volume":"23","author":"Millan","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2025111608424866600_ref31","doi-asserted-by":"publisher","DOI":"10.1111\/jre.70044","article-title":"Targeted alkaline phosphatase therapy enhances alveolar bone healing in X-linked hypophosphatemia in mice","author":"Phanrungsuwan","year":"2025","journal-title":"J Periodontal Res"},{"issue":"4","key":"2025111608424866600_ref32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/0022034520901719","article-title":"Dentoalveolar defects in the Hyp mouse model of X-linked hypophosphatemia","volume":"99","author":"Zhang","year":"2020","journal-title":"J Dent Res"},{"issue":"12","key":"2025111608424866600_ref33","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1073\/pnas.73.12.4667","article-title":"Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets","volume":"73","author":"Eicher","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2025111608424866600_ref34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1469-7580.2011.01367.x","article-title":"Tooth-bone morphogenesis during postnatal stages of mouse first molar development","volume":"218","author":"Lungova","year":"2011","journal-title":"J Anat"},{"issue":"2","key":"2025111608424866600_ref35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jbmr.1767","article-title":"Tooth root dentin mineralization defects in a mouse model of hypophosphatasia","volume":"28","author":"Foster","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025111608424866600_ref36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/0022034510393517","article-title":"Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia","volume":"90","author":"McKee","year":"2011","journal-title":"J Dent Res"},{"issue":"8","key":"2025111608424866600_ref37","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/jbmr.1619","article-title":"Enzyme replacement prevents enamel defects in hypophosphatasia mice","volume":"27","author":"Yadav","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025111608424866600_ref38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bone.2011.03.770","article-title":"Dose response of bone-targeted enzyme replacement for murine hypophosphatasia","volume":"49","author":"Yadav","year":"2011","journal-title":"Bone"},{"issue":"9","key":"2025111608424866600_ref39","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/jbmr.4038","article-title":"Visualization of mineral-targeted alkaline phosphatase binding to sites of calcification in vivo","volume":"35","author":"Amadeu de Oliveira","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025111608424866600_ref40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/path.5346","article-title":"Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model","volume":"250","author":"Tani","year":"2020","journal-title":"J Pathol"},{"issue":"1","key":"2025111608424866600_ref41","doi-asserted-by":"publisher","first-page":"e10709","DOI":"10.1002\/jbm4.10709","article-title":"Gene therapy using recombinant AAV type 8 vector encoding TNAP-D(10) improves the skeletal phenotypes in murine models of osteomalacia","volume":"7","author":"Amadeu de Oliveira","year":"2023","journal-title":"JBMR Plus"},{"issue":"3","key":"2025111608424866600_ref42","doi-asserted-by":"publisher","first-page":"e10474","DOI":"10.1002\/jbm4.10474","article-title":"Guidelines for micro-computed tomography analysis of rodent dentoalveolar tissues","volume":"5","author":"Chavez","year":"2021","journal-title":"JBMR Plus"},{"issue":"3","key":"2025111608424866600_ref43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ijos.2012.57","article-title":"Methods for studying tooth root cementum by light microscopy","volume":"4","author":"Foster","year":"2012","journal-title":"Int J Oral Sci"},{"key":"2025111608424866600_ref44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bone.2015.05.007","article-title":"Mineralization defects in cementum and craniofacial bone from loss of bone sialoprotein","volume":"78","author":"Foster","year":"2015","journal-title":"Bone"},{"key":"2025111608424866600_ref45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bone.2017.12.004","article-title":"Osteopontin regulates dentin and alveolar bone development and mineralization","volume":"107","author":"Foster","year":"2018","journal-title":"Bone"},{"issue":"8","key":"2025111608424866600_ref46","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4829","article-title":"Dentoalveolar alterations in an adenine-induced chronic kidney disease mouse model","volume":"38","author":"Mohamed","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025111608424866600_ref47","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf005","article-title":"Preclinical evaluation of the efficacy and safety of AAV8-TNAP-D10 in Alpl\u2212\/\u2212 and AlplPrx1\/Prx1 mouse models for the treatment of early and late-onset hypophosphatasia","volume":"40","author":"de Oliveira","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025111608424866600_ref48","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1177\/00220345221100794","article-title":"The bone sialoprotein RGD domain modulates and maintains periodontal development","volume":"101","author":"Nagasaki","year":"2022","journal-title":"J Dent Res"},{"issue":"5","key":"2025111608424866600_ref49","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1210\/clinem\/dgae398","article-title":"Improved oral health in adults with X-linked hypophosphatemia treated with burosumab","volume":"110","author":"Herve","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025111608424866600_ref50","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025111608424866600_ref51","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1210\/clinem\/dgaf093","article-title":"X-linked hypophosphatemia management in children: an International Working Group Clinical Practice Guideline","volume":"110","author":"Ali","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025111608424866600_ref52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/10454411000110030101","article-title":"Osteopontin","volume":"11","author":"Sodek","year":"2000","journal-title":"Crit Rev Oral Biol Med"},{"issue":"4","key":"2025111608424866600_ref53","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1359\/jbmr.090832","article-title":"Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage","volume":"25","author":"Addison","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025111608424866600_ref54","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1359\/jbmr.080601","article-title":"MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM","volume":"23","author":"Addison","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025111608424866600_ref55","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"2025111608424866600_ref56","doi-asserted-by":"publisher","first-page":"e0234073","DOI":"10.1371\/journal.pone.0234073","article-title":"Viral delivery of tissue nonspecific alkaline phosphatase diminishes craniosynostosis in one of two FGFR2C342Y\/+ mouse models of Crouzon syndrome","volume":"15","author":"Nam","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"2025111608424866600_ref57","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/00220345211005677","article-title":"Delivery of alkaline phosphatase promotes periodontal regeneration in mice","volume":"100","author":"Nagasaki","year":"2021","journal-title":"J Dent Res"},{"issue":"11","key":"2025111608424866600_ref58","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1021\/cr0782729","article-title":"Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition","volume":"108","author":"George","year":"2008","journal-title":"Chem Rev"},{"key":"2025111608424866600_ref59","doi-asserted-by":"crossref","first-page":"115447","DOI":"10.1016\/j.bone.2020.115447","article-title":"Biological stenciling of mineralization in the skeleton: local enzymatic removal of inhibitors in the extracellular matrix","volume":"138","author":"Reznikov","year":"2020","journal-title":"Bone"},{"issue":"4","key":"2025111608424866600_ref60","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0022034516677528","article-title":"Phosphate and vitamin D prevent periodontitis in X-linked hypophosphatemia","volume":"96","author":"Biosse Duplan","year":"2017","journal-title":"J Dent Res"},{"key":"2025111608424866600_ref61","first-page":"193","volume-title":"The contributions of osteopontin to dentoalveolar defects in X-linked hypophosphatemia. College of Dentistry","author":"Phanrungsuwan","year":"2025"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziaf166\/64856525\/ziaf166.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/12\/ziaf166\/64856525\/ziaf166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/12\/ziaf166\/64856525\/ziaf166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T13:42:53Z","timestamp":1763300573000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziaf166\/8296969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf166","relation":{},"ISSN":["2473-4039"],"issn-type":[{"type":"electronic","value":"2473-4039"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,10,22]]},"article-number":"ziaf166"}}